
Valink presents at Curious2024 Ignite Session
March 24, 2021
LiliumX is proud to graduate from the Y Combinator startup accelerator in their Winter 2021 batch. With an acceptance rate of approximately 1%, the renowned program provides initial funding and mentorship to promising start-ups. Y Combinator has successfully launched companies such as Ginkgo Bioworks, Airbnb, and Dropbox. The program provided valuable training resources, a wide network of other tech and biotech companies, as well as a $125,000 initial investment.
"We are grateful to be a part of the Y Combinator network, and have thoroughly enjoyed the 3-month remote program. Y Combinator was integral to LiliumX's early successes and has set a steep trajectory for the company."
- Arne Scheu, CEO of LiliumX
For more information, read TechCrunch's Y Combinator Winter 21 news coverage here or see LiliumX’s company overview at Y Combinator’s portfolio here.
More News
Contact us
Valink Therapeutics Inc
One Broadway,
Cambridge,
Massachusetts,
02142
Valink Therapeutics Ltd
Imperial I-Hub,
84 Wood Lane,
London,
W12 0BZ
Design & built by The Sourdough